Tanaka et al. [32] first reported that many interferon-gamma-inducible genes including PD-L1 and cytotoxic T-lymphocyte markers such as perforin (PRF1) and granzyme B (GZMB) were activated by chemoradiotherapy in ESCC. The gene discussed is GZMB; the disease is esophageal squamous cell carcinoma.